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Summary. Objectives. The aim of this study was to identify the predictors of the postreperfusion
mode of death using the distinctions in clinical characteristics of patients who died and survived
after reperfusion therapy, treated due to ST-elevation myocardial infarction (STEMI).
Material and methods. This consecutive study has involved 36 patients: 18 patients who died
from progressive heart failure (PHF) (group 1, n=13) or from cardiac rupture (CR) (group 2,
n=5) after primary coronary intervention. The control group consisted of 18 randomly selected
patients who survived inhospital period (group 3). The initial and postreperfusion heart rate
(HR), systolic and diastolic arterial pressures (SAP and DAP), maximal ST elevation (max ST­)
and depression (max ST¯), ST score, TIMI flow grade, coronary score (CS), and their
perireperfusion changes were assessed for each patient. The complex prognostic predictors –
TIMI Risk Score and TIMI Risk Index – were also assessed. The data analysis was performed by
standard statistical and machine learning approach methods.
Results. The comparison of three patients’ groups according to simple ECG or circulatory
characteristics showed that more significant differences were seen in postreperfusion
characteristics or their perireperfusion changes. Herewith, the major part of significantly different
characteristics (baseline SAP, DAP, and HR, postreperfusion SAP, DAP, ST score, and TIMI
flow grade, resolution of ST score) was observed comparing both the groups of dead patients
with survivors (control group). The differences in the complex predictors (TIMI Risk Score and
TIMI Risk Index) were similar. However, the smallest number of significantly different
characteristics was seen comparing both the groups of dead patients. The baseline DAP
(P=0.045), postreperfusion SAP (P=0.04) and DAP (P=0.03), and ST score (P=0.0025) were
higher in the patients who died from CR. The postreperfusion ST score and SAP were also
identified as necessary components in the assessment of informative prognostic sets according
to feature selection methods used in data mining field.
Conclusion. The postreperfusion ST score, SAP, and DAP could be useful for the prediction
of inhospital postreperfusion mode of death in patients with STEMI; evidently more clinical
predictors could be useful for the prediction of general occurrence of postreperfusion deaths.
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Introduction
Recent clinical trials suggest that the increased 30-
day mortality in patients with ST-elevation myocar-
dial infarction (STEMI) can be significantly reduced
with the use of early reperfusion therapy (RT) (1–3).
However, it seems likely that the current use of RT
has a minimal causal impact on hospital mortality
rates principally because sometimes technically
successful RT is associated with more acute cardiac
and vascular complications (4, 5). The increased
paradoxical risk of death has been reported in patients
during the first 24 hours after RT (6–8). The real
mechanism of this phenomenon, excluding the me-
chanism of recurrent myocardial ischemia (4, 9), is
not exactly known (10). Additionally, the mechanisms
of postreperfusion deaths may be different and
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manifested as the sudden death from life-threatening
arrhythmia, death from cardiac rupture (CR), and
death from progressive heart failure (PHF) (6, 11, 12).
The prediction of postreperfusion mode of death is
consequently underestimated clinical problem (12–
14). The lack of an adequate or consistent classifi-
cation of modes of deaths contributes to the current
confusion in analyzing the causes of postreperfusion
mortality also.
The rationale usage of different methods of sta-
tistical data analysis may be valuable in identification
of clinical predictors (15, 16). The main objective of
feature selection is obtaining a feature space with 1)
low dimensionality, 2) retention of sufficient infor-
mation, and 3) enhancement of separability in feature
space, for example, in different categories by remov-
ing effects due to noisy features.
The aim of this study was to identify the possible
predictors and sets of predictors of the postreperfusion
mode of death using the distinctions in clinical charac-
teristics of dead patients and survivors, treated by pri-




In this consecutive study, we tried to identify the
informative clinical characteristics suitable for pre-
diction of postreperfusion mode of death using the
discrepancies in simple and complex clinical charac-
teristics of 36 patients with STEMI, who died or sur-
vived inhospital period and underwent primary PCI
in the Department of Cardiology of Kaunas Univer-
sity of Medicine during 2003. The patients’ circu-
latory status (heart rate, systolic and diastolic arterial
blood pressure), electrocardiography data (QRS score,
maximal ST-segment elevation and depression, and
total ST dislocation [ST score]), angiography data
(postreperfusion TIMI flow, coronary score), and po-
pular complex prognostic characteristics – the TIMI
risk score (17–19) and the TIMI risk index (20) –
were assessed for each patient and compared between
survivors and dead patients. The autopsy patients
(n=18) were divided into 2 groups: those who died
from PHF (group 1, n=13) and who died from CR
(group 2, n=5). The control group consisted of the ran-
domly selected survivors (group 3, n=18). The mode
of death was verified by autopsy data in all the cases.
Patients’ selection criteria
The inclusion criteria for all dead patients and
survivors were as follows: 1) typical chest pain longer
than 30 min in duration; 2) ST-segment elevation of
³1 mm (at the J point) in two or more contiguous
leads on 12-lead ECG at admission. Treatment assign-
ment was not randomized, and patients were treated
with PCI by the judgment of the attending cardiologist
based on availability of the catheterization team,
presenting characteristics, and duration of symptoms.
Exclusion criteria were as follows: concomitant val-
vular or myopathic heart disease, intraventricular
conduction defects, and previous coronary artery by-
pass graft surgery. The written informed consent was
obtained from all the cases before treatment.
Electrocardiogram evaluation
The serial 12-lead ECG, recorded at admission and
after PCI, were analyzed using the following criteria:
1) a Selvester QRS score; 2) maximal ST-segment
elevation and depression in mm in the target lead;
and 3) a total ST dislocation (ST score).
The QRS score proposed and modified by Wagner
and others (21–23) was calculated manually by two
observers for each electrocardiogram.
The maximal ST-segment elevation and depres-
sion in mm were measured at the J point of ECG leads
with maximal ST-segment elevation and depression.
The total ST score was calculated as the arithmetic
sum of ST-segment elevation and depression in each
lead and taken as an average value for one of three
standard LV regions (regional ST score). The relevant
leads for the anterior region were V1 to V4; for lateral,
I, aVL, V5, and V6; and for inferior, II and aVF. The
sum of averaged ST-segment dislocations in all LV
regions was defined as total ST score.
Technique of percutaneous coronary
interventions
The primary PCI were performed using the bra-
chial or femoral approach and the Judkins’ technique.
Multiple-view coronary angiography was performed
in all the patients. The degree of “culprit lesion” and
coronary artery stenosis were defined as the greatest
percentage reduction of luminal diameter in any view
compared with the nearest normal segment (percent
diameter stenosis) and was determined using the DSA
computerized technique. The coronary score was cal-
culated as the number of coronary artery segments
with >50% stenosis. All patients undergoing balloon
angioplasty were supplemented with stenting in cases
of suboptimal PTCA results, which included dissec-
tion and/or residual “culprit lesion” stenosis of >30%.
Antegrade blood flow in the infarct artery was grad-
ed using the Thrombolysis in Myocardial Infarction
(TIMI) scale (24).
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Assessment of complex predictors
The TIMI risk score (19) based upon 10 various
clinical risk indicators (age, diabetes mellitus, history
of hypertension and angina pectoris, systolic blood
pressure of <100 mm Hg, Killip class, heart rate, body
weight of <67 kg, anterior ST elevation or left bundle
branch block, time to reperfusion of >4 h) and TIMI
risk index based on combination of a patient’s age, heart
rate and systolic blood pressure at admission (20)
were used for prediction of short-term mortality also.
Evaluation of autopsy data
Each autopsy report was reviewed for the follow-
ing: 1) the premortem coronary thrombus, and 2) the
presence of significant stenosis (25). The different
cardiovascular causes and modes of deaths were
defined according to autopsy findings. PHF was con-
sidered as the cause of death in cases of occluded or
patent infarct-related artery and typical changes of
circulatory congestion in the lungs and other organs.
PHF was defined as the death from pump failure even
if the terminal event was associated with an arrhyth-
mia. CR was assessed as the cause of death by de-
tection and localizing of a rupture, and by estimation
of its length and the amount of blood in the pericardial
sac.
Data analysis
A. Statistical analysis approach
Data were expressed as mean ± SD. Differences
of values between patients’ groups were assessed with
the one-way ANOVA followed by a post hoc Bon-
ferroni t test analysis. Parameters before and after PCI
were tested using the t test for paired samples. P<0.05
was considered significant.
B. Machine learning approach
In our study, we decided not to limit to one app-
roach in selection of informative features but to look
at four of them. For selection of predictor subset, we
used the method described in the book by Hall (1998)
(26). In this book, the value of a subset of features is
evaluated by considering the individual predictive abi-
lity of each feature along with the degree of redun-
dancy among them. The features that are highly cor-
related with the outcome while having low intercorre-
lation were preferred. The best subset among others
was selected by using two methods: genetic algorithm
and backward greedy search. Also we used random
decision trees (27) and linear support vector machines
(15). A bootstrap procedure was used to stabilize the
variable selection methods.
Results
Differences in baseline clinical characteristics
The baseline clinical characteristics are shown in
Table 1. No significant differences in the initial ECG
data were observed comparing all groups. More sig-
nificant differences were recorded comparing circu-
latory characteristics among the groups. The initial
Table 1. The baseline characteristics of patients’ groups
Group 1 Group 2 Group 3
    Clinical characteristic patients dead patients dead survivors P value
from PHF, n=13 from CR, n=5 n=18
Circulatory characteristics
SAP, mm Hg 102.7±35.59 117.4±20.09 144.6±30.02 1 vs. 3, P=0.0007
2 vs. 3, P=0.035
DAP, mm Hg 61.4±23.99 82.2±14.28 88.4±16.16 1 vs. 3, P=0.0004
1 vs. 2, P=0.045
HR, beats per min 89.8±32.18 86.8±34.33 79.9±12.84
ECG characteristics
QRS score 3.84±2.91 4.0±3.24 2.64±1.96 NS
Total ST score 5.07±2.25 7.0±2.82 5.94±1.95 NS
Maximal ST­, mm 3.7±2.46 5.4±3.28 3.5±1.76 NS
Maximal ST¯, mm 2.1±2.01 2.8±2.16 4.6±3.05 NS
Coronary angiography characteristics
TIMI flow grade 0.0±0.0 0.2±0.44 0.55±0.92 NS
Coronary score 4.38±1.38 3.0±2.91 3.0±1.60 1 vs. 3, P=0.009
Data presented are mean value ± SD. CR, cardiac rupture; DAP, diastolic arterial pressure; HR, heart rate;
Max ST­, maximal ST elevation in mm; Max ST¯, maximal ST depression in mm; PHF, progressive heart failure;
SAP, systolic arterial pressure; TIMI, Thrombolysis in Myocardial Infarction; NS, not significant.
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systolic arterial pressure (SAP) in the survivors was
higher than in the patients who died from PHF and
CR (P=0.0007 and P=0.035). The initial diastolic arte-
rial pressure (DAP) in the survivors and patients who
died from CR was the similar; however, it was higher
in the survivors than in the patients who died from
PHF (P=0.0004). There was no difference in the co-
ronary score (CS) between the survivors and patients
dead from CR, but it was greater in the patients who
died from PHF than survivors (P=0.009). There was
no difference in the TIMI flow grade and HR com-
paring all the patients’ groups.
Differences in postreperfusion characteristics
The postreperfusion clinical characteristics are
shown in Table 2. Evidently, postreperfusion
characteristics showed more significant differences.
Postreperfusion systolic and diastolic arterial pres-
sures remained the lowest in the patients who died
from PHF (group 1 vs. group 3, P=0.00001; group 2
vs. group 3, P=0.0051; and group 1 vs. group 2,
P=0.04 and group 1 vs. group 3, P=0.00001; group 2
vs. group 3, P=0.027; and group 1 vs. group 2,
P=0.039, respectively). Coronary reperfusion by
TIMI flow grade was better in survivors than in
patients who died from PHF or CR (group 1 vs. group
3, P=0.0014; group 2 vs. group 3, P=0.0009). The
postreperfusion ECG characteristics, contrary to ba-
seline ECG characteristics, revealed a significant dif-
ference in ST score between both the groups of dead
patients. The postreperfusion ST score in the patients
dead from CR (5.8±3.11) was higher as compared
with patients dead from PHF (3.46±1.66; P=0.0025)
and control patients (1.61±1.09; P=0.0001). However,
no changes in maximal ST­ or ST¯ were seen be-
tween both the groups of dead patients; the maximal
ST­ and ST¯ were significantly higher in the patients
who died from PHF and CR, respectively, than in sur-
vivors (P=0.0041 and P=0.0002, respectively). No
more differences in other parameters were seen com-
paring both the groups of dead patients.
Perireperfusion clinical characteristics
in different patients groups
The periprocedural changes in the circulatory cha-
racteristics (heart rate, systolic and diastolic arterial
pressure), TIMI flow grade, and data of ECG were
expressed by quantitative difference in the baseline
and postreperfusion clinical characteristics. The cir-
culatory characteristics showed no significant changes
in all the groups during PCI. The significant changes
in TIMI flow grades were equally expressed in all
Table 2. Postreperfusion clinical characteristics of patients’ groups
Group 1 Group 2 Group 3
    Clinical characteristic patients dead patients dead survivors P value
from PHF, n=13 from CR, n=5 n=18
Circulatory characteristics
SAP, mm Hg 85.5±20.63 106.8±26.21 131.0±13.89 1 vs. 2, P=0.04
1 vs. 3, P=0.00001
2 vs. 3, P=0.0051
DAP, mm Hg 53.8±18.83 72.8±20.47 85.1±8.79 1 vs. 2, P=0.039
1 vs. 3, P=0.00001
2 vs. 3, P=0.027
HR, beats per min 116.8±38.17 100.4±37.95 79.5±14.21 1 vs. 3, P=0.0003
2 vs. 3, P=0.03
ECG characteristics
QRS score 5.46±3.04 5.6±3.64 4.77±2.23 NS
ST score 3.46±1.66 5.8±3.11 1.61±1.09 1 vs. 2, P=0.0025
1 vs. 3, P=0.0004
2 vs. 3, P=0.0001
Max ST­, mm 2.9±1.97 4.0±2.73 1.22±1.0 1 vs. 3, P=0.0041
Max ST¯, mm 1.15±1.28 2.6±2.3 0.61±0.6 2 vs. 3, P=0.0002
Postreperfusion flow in infarct related artery
TIMI flow grade 2.0±1.22 2.2±0.83 2.94±0.24 1 vs. 3, P=0.0014
2 vs. 3, P=0.0009
Data presented are mean value ± SD. CR, cardiac rupture; DAP, diastolic arterial pressure; HR, heart rate;
Max ST­, maximal ST elevation in mm; Max ST¯, maximal ST depression in mm; PHF, progressive heart failure;
SAP, systolic arterial pressure; TIMI , Thrombolysis in Myocardial Infarction; NS, not significant.
Identification of predictors of postreperfusion inhospital mode of death
108
Medicina (Kaunas) 2010; 46(2)
the groups (P<0.0001); however, a periprocedural re-
solution of ST score was mostly expressed in survivors
(P<0.00001), less expressed in the group 1 (P=0.024),
and in the patients who died from CR, there was no
significant resolution at all. A statistically significant
resolution of max ST­ (P<0.0001) and max ST¯
(P<0.0001) was achieved in survivors only.
Table 3 shows significant perireperfusion changes
in DST-segment comparing different groups. The
difference in the total ST score was the highest in the
control group, as the differences in max ST­ and max
ST¯ were the lowest in the patients who died from
PHF and CR, respectively.
The complex characteristics in different
patients’ groups
The substantial difference in the complex predic-
tors – the TIMI risk score and the TIMI risk index –
was detected between both the groups of dead pa-
tients and survivors (Table 4); however, there were
no differences in these parameters comparing both
the groups of patients with different mode of death.
The identification of prognostic sets
of characteristics (features) using different
data mining methods of feature selection
The sets of prognostic characteristics (features)
obtained by different data-mining methods are shown
in Table 5. The comparison of the sets of characteris-
tics showed that the total ST score, SAP after RT,
and TIMI risk index felt into all the sets selected by
different methods.
Discussion
Previous trials have showed that the myocar-
dial infarct size (28, 29), female gender, elder age,
Table 3. Perireperfusion changes in DST-segment dislocation in all patients’ groups
Table 4. TIMI risk score and TIMI risk index in dead patients and survivors
Group 1 Group 2 Group 3
    Clinical characteristic patients dead patients dead survivors P value
from PHF, n=13 from CR, n=5 n=18
Total DST score, mm 1.6±1.8 1.2±1.3 4.2±2.3 1 vs. 3, P=0.0021
2 vs. 3, P=0.01
Max DST­, mm 0.7±1.43 1.4±1.14 2.3±1.8 1 vs. 3, P=0.025
Max DST¯, mm 0.9±1.4 0.2±1.3 1.77±1.36 2 vs. 3, P=0.04
Data presented are mean value ± SD. Only the statistically significant differences are shown in this table.
CR, cardiac rupture; PHF, progressive heart failure.
Group 1 Group 2 Group 3
Risk stratification method patients dead patients dead survivors P value
from PHF, n=13 from CR, n=5 n=18
TIMI Risk Score 9.76±2.35 9.0±2.44 5.0±2.05 1 vs. 3, P=0.00001
2 vs. 3, P=0.0006
TIMI Risk Index 48.61±26.7 43.76±25.92 21.31±8.68 1 vs. 3, P=0.0002
2 vs. 3, P=0.002
Data presented are mean value ± SD. Only the statistically significant differences are shown in this table.
TIMI, Thrombolysis in Myocardial Infarction.
Table 5. The most informative sets of characteristics (features) suitable for prognosis of in-hospital mode of death obtained
using four different methods of feature selection (feature are presented in order of importance)
     Genetic algorithm     Greedy backward search     Random decision tree           Linear SVM
SAP initial SAP initial SAP postreperfusion SAP postreperfusion
SAP postreperfusion SAP postreperfusion DAP postreperfusion ST score postreperfusion
DAP initial DAP initial TIMI Risk Score SAP initial
TIMI Risk Index TIMI Risk Score DAP initial TIMI SAP
Max ST depression initial TIMI Risk Index Total ST score initial TIMI Risk Score
ST score postreperfusion Max ST depression initial TIMI Risk Index DAP postreperfusion
Coronary score ST score postreperfusion ST score postreperfusion TIMI Risk Index
DAP, diastolic arterial pressure; SAP, systolic arterial pressure; SVM, support vector machine.
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hypertension with LV hypertrophy (1, 2, 9, 30), in-
creased coronary injury score (10, 30, 31) are associ-
ated with increased general intrahospital mortality
after RT. The circulatory disorders such as hypoten-
sion, sinus tachycardia, and left ventricle failure (7,
9, 10, 32) have been mentioned by other authors as
more important predictors of early postreperfusion
death. The present study dedicated for identification
of clinical characteristics for the prediction of
postreperfusion death is important in identification
of the predictors of life-threatening complications,
which determine the occurrence of death due to PHF,
CR, or arrhythmia. Therefore, the specific distinc-
tions in clinical characteristics of patients who died
due to different pathologic mechanism and survivors
could be informative. The prediction of a postreper-
fusion mode of death is underestimated, and it is an
important clinical problem especially due to the ex-
isting opinion that early obtained and appreciated pre-
dictors usually enable to prevent of life-threatening
complications and postreperfusion deaths (19, 20, 33,
34).
The possibilities for prediction of imminent CR
in postinfarction patients have been studied by many
authors previously (35–37). CR most commonly pre-
sents in elderly women with anterior STEMI and pa-
tients with the first STEMI, not preceded by angina.
The primary PCI had a striking impact on reducing
the incidence of ventricular septal rupture after AMI
compared to elective PCI in patients who did not re-
ceive thrombolytic therapy. Advanced age, female
gender, anterior infarction, and low body mass index
had potentially increased the risk of this catastrophic
complication after AMI in large population. However,
the predictors of postreperfusion CR are not clear.
Our experience confirms the opinion that successful
coronary reopening of infarct-related artery assessed
by TIMI flow grade is not so important for occur-
rence of CR as the insufficient adequacy of myocar-
dial reperfusion expressed by ST resolution (35, 36).
So, early and successful RT may be the most power-
ful determinant of the avoidance of this catastrophic
complication after STEMI (38). The increased
postreperfusion systolic and diastolic arterial pres-
sure may be valuable for the occurrence of CR also.
In our material, an increased coronary score was more
common among patients who died from PHF (39).
According to our data, the complex risk predic-
tors – the TIMI risk score and TIMI risk index – were
less significant in the prediction of mode of death.
The TIMI risk score derived from 10 initial clinical
indicators (age, weight, heart rate, systolic blood
pressure, Killip class, diabetes mellitus, hypertension,
time to RT, ST­) could be informative for the predic-
tion of general early postreperfusion mortality after
STEMI. The TIMI risk index had approximately the
same prognostic value based on combination of three
indicators (age, heart rate, and systolic arterial pres-
sure). Other complex predictors used in the PURSUIT,
PREDICT, and other trials (31) were not adequately
tested for prediction of the postreperfusion mode of
death.
The lack of an adequate or consistent classifica-
tion of how patients die contributes to the current
confusion over the predicting of the mode of death.
A demand and propositions for more accurate classi-
fication are evident, because the postmortem exami-
nation is generally accepted as the gold standard for
determining the real causes and mechanisms of death
(40). A framework for the classification of the mode
of death has been developed in two mortality stud-
ies: AIRE and NETWORK (25). Simon et al. (41)
developed a new scheme for classifying cardiac death
that defines 3 categories of underlying mechanism:
primary arrhythmia, acute myocardial ischemia/inf-
arction, and myocardial pump failure. It is possible,
using these data, to classify the cardiac deaths not
only based on death timing, but based on its mecha-
nism (arrhythmia, ischemia, CR, PHF) (13, 14). In
our study, we followed the classification, which pro-
vides a useful algorithm for classifying deaths by
underlying mechanism. However, the correct assess-
ment of death mechanism is dependent on the bias of
the investigator, and we had difficulties with differ-
entiation of modes of death also (14). After RT, the
residual myocardial stunning, functional myocardial
insufficiency, and PHF dominated in our study; how-
ever, by other authors, about 47% of deaths were clas-
sified as arrhythmic, 43% as ischemic, and 8% as due
to PHF. Different interpretation of mode and cause
of death worsens the identification of specific pre-
dictors of different modes of deaths. The optimized
classification will minimize inconsistencies, but it
does not solve the problem that the mechanism of
death is difficult sometimes to assign (14), although
diagnosis of death in many situations (reocclusions,
reinfarctions, CR) is unchallenged.
The usage of different statistic approaches may
be valuable for identification of predictors also. The
machine learning methods in the evaluation of the most
informative features sets were used in this study. Se-
lection of informative features (characteristics) has
been an active research area in statistics, machine learn-
ing and data mining communities. Feature selection
Identification of predictors of postreperfusion inhospital mode of death
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is the problem of choosing a small subset of features
that ideally is necessary and sufficient to describe the
target concept. There are several reasons for selecting
only a subset of the features (characteristics):
1. It is cheaper to measure only a subset of variables;
2. Prediction accuracy might be improved through
exclusion of irrelevant variables;
3. The predictor to be built is usually simpler and
potentially faster when less input variables are
used;
4. Knowing which variables are relevant can give
insight into the nature of the prediction problem
at hand (16).
When a number of features are comparatively high
to a number of observations, the prognostic models
and the informative feature subsets are very unstable.
To reduce the number of features, we used not rough
features but integrated indices (QRS score, ST score,
TIMI risk index, TIMI risk score).
Simply the selection of the top-ranked features is
not a good approach. A limitation of this approach is
that the features could be correlated among themsel-
ves and does not form a good feature set. This suggests
that redundancy of predictor set is one of the critical
issues to consider.
The approaches for feature selection are very di-
verse and motivated by various theoretical arguments.
In our study, we decided not to limit to one approach
in selection of informative features but to look at four
of them. For evaluation of feature subset, we used
method described by Hall (26), where the value of a
subset of attributes is evaluated by considering the
individual predictive ability of each feature along with
the degree of redundancy between them. The features
that are highly correlated with the outcome while
having low intercorrelation are preferred. The back-
ward greedy search and genetic algorithm (42) show
good results comparable to exhaustive search but
requires significantly less computation resources. The
recent developments in feature selection revealed that
classification algorithms like random decision trees
(27) and linear support vector machines (15) are also
efficient methods of feature search.
To stabilize variable selection, we used a bootstrap
procedure. The variable selection process was re-
peated with subsamples of the training data, and the
union of the subsets of variables selected in the va-
rious bootstraps was taken as the final stable feature
subset. This joint feature subset is at least as predictive
as the best bootstrap subset.
Limitations
We had no possibility to include more patients and
more clinical characteristics such as angiographic
TIMI count or myocardial blush grade, angiographic
perfusion score, and others. In many circumstances,
it may be desirable to utilize more complex risk stra-
tification systems. However, we have shown that so-
metimes simple predictors may be more effective in
prediction of mode of death after RT than more com-
plex risk assessment tools.
Conclusions
1. The popular complex prognostic criteria – TIMI
risk score and TIMI risk index as postreperfusion
TIMI flow grade – are informative for prediction of
early general mortality, but not informative for pre-
diction of the postreperfusion inhospital mode of
death.
2. The high total ST score expressed in mm and
absence of adequate ST resolution during reperfusion
therapy could be used as a possible predictor for
occurrence of inhospital cardiac rupture.
3. Low postreperfusion systolic and diastolic ar-
terial pressures, which remained the same or decreas-
ed after reperfusion especially in combination with
high coronary score, could be predictive for occur-
rence of death from progressive heart failure.
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